Sonova Holding (OTCMKTS:SONVY) Short Interest Up 426.1% in December

Sonova Holding (OTCMKTS:SONVY) was the target of a significant increase in short interest in the month of December. As of December 31st, there was short interest totaling 11,510 shares, an increase of 426.1% from the December 15th total of 2,188 shares. Based on an average daily volume of 52,730 shares, the short-interest ratio is presently 0.2 days. Approximately 0.0% of the company’s shares are sold short. Approximately 0.0% of the company’s shares are sold short. Based on an average daily volume of 52,730 shares, the short-interest ratio is presently 0.2 days.

Analysts Set New Price Targets

Several equities analysts have weighed in on SONVY shares. Zacks Research lowered Sonova from a “hold” rating to a “strong sell” rating in a research note on Tuesday, December 9th. BNP Paribas initiated coverage on Sonova in a research note on Monday, October 20th. They issued an “underperform” rating for the company. Royal Bank Of Canada upgraded shares of Sonova to a “moderate buy” rating in a research report on Tuesday, November 18th. Finally, Rothschild Redb upgraded shares of Sonova from a “strong sell” rating to a “hold” rating in a report on Monday, October 6th. One analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating, four have issued a Hold rating and three have assigned a Sell rating to the company. According to MarketBeat.com, the stock has an average rating of “Hold”.

Sonova Stock Performance

OTCMKTS:SONVY opened at $53.33 on Tuesday. The company has a current ratio of 1.24, a quick ratio of 0.91 and a debt-to-equity ratio of 0.51. The business’s 50-day simple moving average is $51.30 and its 200-day simple moving average is $55.06. Sonova has a fifty-two week low of $47.55 and a fifty-two week high of $71.50.

Sonova Company Profile

Sonova AG (OTCMKTS:SONVY) is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.

Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems.